SNPs in FNDC5 (irisin) are associated with obesity and modulation of glucose and lipid metabolism in Saudi subjects
Open Access
- 11 March 2016
- journal article
- research article
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 15 (1) , 1-8
Abstract
Irisin is a recently identified myokine that plays an important role in preventing obesity and insulin resistance. We investigated whether the common FNDC5 (irisin precursor) gene variants influence susceptibility to obesity and type 2 diabetes (T2D) and verified the impact of FNDC5 gene variants on serum irisin levels, glucose and lipid metabolism in a Saudi population. Genomic DNA from 814 (394 T2DM and 414 controls) subjects were genotyped for the five common SNPs (rs3480A/G, rs1746661G/T, rs1298190A/G, rs726344A/G and rs1570569G/T) of the FNDC5 gene using the TaqMan genotyping assay. Biochemical parameters and hematic concentrations of irisin and insulin as well as anthropometric indices were collected. Serum irisin levels were higher in T2DM patients compared to controls (p < 0.0001). Analyses of FNDC5 SNPs showed that: 1) The rs3480 GG associates with decreased risk of obesity (p = 0.005; odds ratio: 0.48) and lower body mass index (BMI) values (p = 0.03). In addition, GGAAG was identified as the protective haplotype against risk of obesity (p = 0.001; odds ratio: 0.23). 2) The rs1746661 G allele associates with higher triglyceride (TG) levels (p = 0.019). 3) The rs157069 TT genotype associates with higher fasting insulin (p = 0.029) and HOMA-IR (p = 0.002) as well as with lower circulating irisin levels (p = 0.016). SNPs in FNDC5 gene correlates with obesity and glucose-lipid metabolism possibly because they modulate the serum levels of irisin.Keywords
Funding Information
- Deanship of Scientific Research, Prolific Research Group Program, Vice Rectorate for Graduate Studies, and Scientific Research in King Saud University (PRG-1436-15)
This publication has 31 references indexed in Scilit:
- Irisin in obesity and type 2 diabetesJournal of Diabetes and its Complications, 2013
- Lower circulating irisin is associated with type 2 diabetes mellitusJournal of Diabetes and its Complications, 2013
- Decrease in Irisin in Patients with Chronic Kidney DiseasePLOS ONE, 2013
- In vitro brown and “brite”/“beige” adipogenesis: Human cellular models and molecular aspectsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013
- Common Genetic Variation in the Human FNDC5 Locus, Encoding the Novel Muscle-Derived ‘Browning’ Factor Irisin, Determines Insulin SensitivityPLOS ONE, 2013
- A Nonsense Polymorphism (R392X) in TLR5 Protects from Obesity but Predisposes to DiabetesThe Journal of Immunology, 2013
- Serum irisin levels in new-onset type 2 diabetesDiabetes Research and Clinical Practice, 2013
- Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity – Correlation with body mass indexPeptides, 2013
- Lifetime Obesity in Patients with Eating Disorders: Increasing Prevalence, Clinical and Personality CorrelatesEuropean Eating Disorders Review, 2012
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesisNature, 2012